22, 2015 /PRNewswire/ -- Nevro Corp. (NYSE ... of its Premarket Approval Application (PMA) for the Senza spinal cord stimulation (SCS) system. According to the approvable letter, approval ...

Meanwhile, NVRO currently has a market capitalization of $152.5 million. In the last reported quarter, it delivered an earnings surprise of 31.75%. More on Nevro’s HFX iQ and Its Features HFX iQ ...

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its neuromodulation platforms for treating chronic pain. The all-cash deal comes ...